Sonali Phogat case: Goa police detain suspected drug peddler, restaurant owner
Panaji (PTI): The Goa Police on Saturday detained a North Goa restaurant owner and a suspected peddler, who had allegedly supplied drugs to the two accused arrested in the Bharatiya Janata Party (BJP) leader Sonali Phogat murder case, a senior officer said.
The suspected drug peddler, Dattaprasad Gaonkar, was detained from Anjuna after the accused duo "confessed" in their statement that they had procured drugs from him, the officer said.
Another man who has been detained is identified as Edwin Nunes, the owner of Curlies restaurant, where Phogat was partying late at night on August 22 before her death under mysterious circumstances.
Goa Police had arrested Sudhir Sagwan and Sukhwinder Singh accompanying Phogat, a popular TikTok star who hailed from Haryana, to Goa.
Phogat, 42, was brought dead to St Anthony Hospital at Anjuna in North Goa district on August 23 morning from her hotel.
The police on Friday said Sagwan and Singh allegedly mixed some "obnoxious substance" in water and forced Phogat to drink it while partying at Curlies restaurant on the intervening night of August 22 and 23, adding they have been charged with murder.
The motive behind the alleged murder of Phogat could be "economic interest", a senior police officer had said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Ballari maternal deaths: Karnataka govt. seeks explanation from CDSCO
Bengaluru: The Karnataka Government has sought clarification from the Central drugs standard control organisation following reports linking the serial deaths of pregnant women at Ballari District Hospital to unsafe IV Ringer's Lactate solution. Health Department Principal Secretary Harsha Gupta has written a letter to the Drugs Controller General of India, Rajeev Singh Raghuvanshi.
Recent Investigations revealed bacterial and fungal contaminants in the IV solution given to the women. Out of 192 batches supplied by a West Bengal-based pharmaceutical company, 22 were found substandard by the state drug control department, leading to the suspension of the medicine's use.
However, these batches had passed quality tests at the Central Drug Lab, creating a regulatory conflict.
The Health Department emphasized adherence to tender rules, stating that the Central Drug Lab's approval is legally binding. Samples from the problematic batches have been sent for re-testing at the central lab in West Bengal, with results expected on December 9.
As a precautionary measure, the state has blacklisted the implicated batches and issued directives to halt their use in all hospitals.
